omeprazole and vitamin d 2

omeprazole has been researched along with vitamin d 2 in 5 studies

Research

Studies (5)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	1 (20.00)	18.2507
2000's	1 (20.00)	29.6817
2010's	3 (60.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ	1
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K	1
Gagnemo-Persson, R; Hâkanson, R; Persson, P; Samuelsson, A	1
Awni, W; Chan, J; Chira, T; Galitz, L; Palaparthy, R; Pradhan, RS; Rieser, M; Williams, LA	1
Basraoui, D; Buche, S; Coopman, S; Delaporte, E; Deregnaucourt, D; Turck, D	1

Reviews

1 review(s) available for omeprazole and vitamin d 2

Article	Year
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans. Drug discovery today, 2016, Volume: 21, Issue:4 Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk	2016

Trials

1 trial(s) available for omeprazole and vitamin d 2

Article	Year
Effect of omeprazole on the pharmacokinetics of paricalcitol in healthy subjects. Biopharmaceutics & drug disposition, 2007, Volume: 28, Issue:2 Topics: Adolescent; Adult; Anti-Ulcer Agents; Area Under Curve; Biological Availability; Bone Density Conservation Agents; Double-Blind Method; Drug Interactions; Ergocalciferols; Female; Gastric Acidity Determination; Humans; Hydrogen-Ion Concentration; Male; Middle Aged; Omeprazole	2007

Article

Year

Effect of omeprazole on the pharmacokinetics of paricalcitol in healthy subjects.

Biopharmaceutics & drug disposition, 2007, Volume: 28, Issue:2

Topics: Adolescent; Adult; Anti-Ulcer Agents; Area Under Curve; Biological Availability; Bone Density Conservation Agents; Double-Blind Method; Drug Interactions; Ergocalciferols; Female; Gastric Acidity Determination; Humans; Hydrogen-Ion Concentration; Male; Middle Aged; Omeprazole

2007

Other Studies

3 other study(ies) available for omeprazole and vitamin d 2

Article	Year
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development. Toxicological sciences : an official journal of the Society of Toxicology, 2013, Volume: 136, Issue:1 Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests	2013
Chicken parathyroid hormone gene expression in response to gastrin, omeprazole, ergocalciferol, and restricted food intake. Calcified tissue international, 1997, Volume: 61, Issue:3 Topics: Animals; Body Weight; Calcium; Chickens; Ergocalciferols; Food Deprivation; Gastrins; Gene Expression Regulation; Omeprazole; Parathyroid Hormone; Phosphorus; Vitamin D	1997
[Pyoderma gangrenosum with lung involvement treated with infliximab]. Annales de dermatologie et de venereologie, 2013, Volume: 140, Issue:5 Topics: Adolescent; Adrenal Cortex Hormones; Analgesics; Antibodies, Monoclonal; Colectomy; Colitis, Ulcerative; Combined Modality Therapy; Drug Therapy, Combination; Ergocalciferols; Gastrointestinal Hemorrhage; Humans; Immunosuppressive Agents; Infliximab; Lung Diseases; Male; Omeprazole; Postoperative Complications; Proctitis; Pyoderma Gangrenosum; Tomography, X-Ray Computed	2013